Compare SE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SE | BSX |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9B | 65.8B |
| IPO Year | 2017 | 2010 |
| Metric | SE | BSX |
|---|---|---|
| Price | $115.57 | $48.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 22 |
| Target Price | ★ $173.69 | $93.18 |
| AVG Volume (30 Days) | 4.6M | ★ 19.9M |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $32.31 | $11.85 |
| Revenue Next Year | $21.53 | $10.16 |
| P/E Ratio | $49.15 | ★ $33.36 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $77.05 | $42.20 |
| 52 Week High | $199.30 | $109.50 |
| Indicator | SE | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 50.36 |
| Support Level | $80.58 | $47.17 |
| Resistance Level | $116.91 | $50.14 |
| Average True Range (ATR) | 3.86 | 1.59 |
| MACD | -0.84 | -0.15 |
| Stochastic Oscillator | 25.74 | 30.48 |
Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce. Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value. Shopee is a hybrid consumer-to-consumer and business-to-consumer marketplace platform operating in Indonesia, Taiwan, Vietnam, Thailand, Malaysia, the Philippines, and Brazil. For Garena, Free Fire is the key revenue-generating game. Sea's third business, Monee, provides lending, payment, digital banking, and insurance services. As of March 2025, Forrest Li, the founder, chair, and CEO, owned 59.1% of the voting power. Tencent owned 18.5% of issued shares with no voting power.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.